Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. European Union. Regulation (EC) N° 1901/2006 on Medicinal Products for Paediatric Use and Amending Regulation (EEC) N° 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) N° 726/2004. Available at:
http://ec.europa.eu/health/human-use/paediatric-medicines/index_en.htmOR
http://eur-lex.europa.eu/RECH_legislation.do
.
2. European Medicines Agency. Updated priority list (revised) for studies into off-patent paediatric medicinal products. Doc. Ref. EMA/197972/2007. London: EMA, 2007.
3. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552–8.
4. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5(5):703–718. 2.
5. Gore R, Chugh PK, Tripathi CD, Lhamo Y, Gautam S. Pediatric off-label and unlicensed drug use and its implications. Curr Clin Pharmacol. 2017;12(1):18–25.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献